Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther D Kers-Rebel

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|August 21, 2018
Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell FunctionNina Tel-Karthaus, Esther D Kers-Rebel, Maaike W Looman, et al.
Plos One|March 26, 2015
Enterovirus-infected β-cells induce distinct response patterns in BDCA1+ and BDCA3+ human dendritic cellsBarbara M Schulte, Paul R Gielen, Esther D Kers-Rebel, et al.
Plos One|May 3, 2013
Differential susceptibility and response of primary human myeloid BDCA1(+) dendritic cells to infection with different EnterovirusesBarbara M Schulte, Esther D Kers-Rebel, Amy C Prosser, et al.
The Oncologist|January 5, 2019
T-Cell Lymphopenia in Patients with Advanced Thyroid Carcinoma Is Associated with Poor PrognosisKatrin Rabold, Paul R Gielen, Esther D Kers-Rebel, et al.
Traffic (Copenhagen, Denmark)|February 25, 2015
CD14, TLR4 and TRAM Show Different Trafficking Dynamics During LPS StimulationDionne C G Klein, Astrid Skjesol, Esther D Kers-Rebel, et al.
Journal of Medicinal Chemistry|December 14, 2018
Potent Metabolic Sialylation Inhibitors Based on C-5-Modified Fluorinated Sialic AcidsTorben Heise, Johan F A Pijnenborg, Christian Büll, et al.
Cellular and Molecular Life Sciences : CMLS|May 30, 2023
Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7Eline J H van Houtum, Esther D Kers-Rebel, Maaike W Looman, et al.
Pharmaceutics|July 27, 2024
Glioma-Associated Sialoglycans Drive the Immune Suppressive Phenotype and Function of Myeloid CellsLenneke A M Cornelissen, Kim C M Santegoets, Esther D Kers-Rebel, et al.
Neuro-Oncology|March 24, 2016
Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell functionPaul R Gielen, Barbara M Schulte, Esther D Kers-Rebel, et al.
Journal of Neuropathology and Experimental Neurology|April 9, 2015
Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissuePaul R Gielen, Barbara M Schulte, Esther D Kers-Rebel, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|August 21, 2018
Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell FunctionNina Tel-Karthaus, Esther D Kers-Rebel, Maaike W Looman, et al.
Plos One|March 26, 2015
Enterovirus-infected β-cells induce distinct response patterns in BDCA1+ and BDCA3+ human dendritic cellsBarbara M Schulte, Paul R Gielen, Esther D Kers-Rebel, et al.
Plos One|May 3, 2013
Differential susceptibility and response of primary human myeloid BDCA1(+) dendritic cells to infection with different EnterovirusesBarbara M Schulte, Esther D Kers-Rebel, Amy C Prosser, et al.
The Oncologist|January 5, 2019
T-Cell Lymphopenia in Patients with Advanced Thyroid Carcinoma Is Associated with Poor PrognosisKatrin Rabold, Paul R Gielen, Esther D Kers-Rebel, et al.
Traffic (Copenhagen, Denmark)|February 25, 2015
CD14, TLR4 and TRAM Show Different Trafficking Dynamics During LPS StimulationDionne C G Klein, Astrid Skjesol, Esther D Kers-Rebel, et al.
Journal of Medicinal Chemistry|December 14, 2018
Potent Metabolic Sialylation Inhibitors Based on C-5-Modified Fluorinated Sialic AcidsTorben Heise, Johan F A Pijnenborg, Christian Büll, et al.
Cellular and Molecular Life Sciences : CMLS|May 30, 2023
Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7Eline J H van Houtum, Esther D Kers-Rebel, Maaike W Looman, et al.
Pharmaceutics|July 27, 2024
Glioma-Associated Sialoglycans Drive the Immune Suppressive Phenotype and Function of Myeloid CellsLenneke A M Cornelissen, Kim C M Santegoets, Esther D Kers-Rebel, et al.
Neuro-Oncology|March 24, 2016
Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell functionPaul R Gielen, Barbara M Schulte, Esther D Kers-Rebel, et al.
Journal of Neuropathology and Experimental Neurology|April 9, 2015
Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissuePaul R Gielen, Barbara M Schulte, Esther D Kers-Rebel, et al.
Pageof 2